Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 21, 2023 16:05 ET | Source: TransMedics

TransMedics to Present at Upcoming March Investor Conferences

ANDOVER, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
September 28, 2020 16:05 ET | Source: TransMedics

TransMedics Announces Temporary Postponement of OCS Heart FDA Advisory Panel Committee Meeting

ANDOVER, Mass., Sept. 28, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
September 01, 2020 16:30 ET | Source: TransMedics

TransMedics to Present at the 18th Annual Morgan Stanley Global Healthcare Conference

ANDOVER, Mass., Sept. 01, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients...
August 05, 2020 16:01 ET | Source: TransMedics

TransMedics Reports Second Quarter 2020 Financial Results

ANDOVER, Mass., Aug. 05, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
July 28, 2020 16:01 ET | Source: TransMedics

TransMedics to Present at the Canaccord 40th Annual Growth Conference

ANDOVER, Mass., July 28, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
July 23, 2020 08:00 ET | Source: TransMedics

TransMedics to Report Second Quarter 2020 Financial Results on August 5, 2020

ANDOVER, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
May 26, 2020 18:49 ET | Source: TransMedics

TransMedics Announces Pricing of Public Offering of Common Stock

ANDOVER, Mass., May 26, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
May 26, 2020 07:14 ET | Source: TransMedics

TransMedics Announces Proposed Public Offering of Common Stock

ANDOVER, Mass., May 26, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
May 26, 2020 07:09 ET | Source: TransMedics

TransMedics Announces Positive Top-line Results from U.S. Pivotal OCS™ Liver PROTECT Trial

ANDOVER, Mass., May 26, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
May 06, 2020 16:05 ET | Source: TransMedics

TransMedics Reports First Quarter 2020 Financial Results

ANDOVER, Mass., May 06, 2020 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...